Search Results
Found 2 results
510(k) Data Aggregation
(43 days)
The System is indicated for fixation of fractures and non-unions of the ulna, particularly in osteopenic bone.
The Ulna Plating System is comprised of two new low profile plates anatomically contoured for the ulna, existing screws and both system specific and general instrumentation. The plates, locking screws and non-locking screws are manufactured from titanium alloy Ti6Al4V ELI per ASTM F136. All the plates are Type II anodized. The plates incorporate both locking and nonlocking holes that allow the surgeon to stabilize the fracture by the use of compression plating techniques and then obtain neutralization of the construct with the locking screws. The locking screws construct can protect the compression screws while providing relative stability across extensive comminution of in osteopenic bone. The plate material and the inclusion of both locking and non-locking holes are design features also included in the predicate device cleared in K083843. The plates are designed to accept existing 2.7mm locking screws, 2.7mm non-locking screws, and 2.7mm multidirectional screws. The non-locking and locking screws are manufactured from Titanium Alloy per ASTM F-136 and are color anodized. The multidirectional screws are manufactured from Cobalt Chromium Alloy per ASTM 1537. The predicate also includes Cobalt Chromium (ASTM F1537) multidirectional screws. The Ulna Plating System will offer the surgeon several system specific instruments as well as various general instruments to facilitate the installation of the implants.
This document is a 510(k) premarket notification for a medical device called the "Ulna Plating System." It describes the device, its intended use, and argues for its substantial equivalence to previously cleared predicate devices.
Here's an analysis of the acceptance criteria and study information provided, structured according to your request:
1. Table of Acceptance Criteria and Reported Device Performance
Acceptance Criteria Category | Reported Device Performance |
---|---|
Mechanical Performance (Construct Testing per ASTM F382) | Results indicate substantial equivalence to legally marketed devices. |
Mechanical Performance (4-point bend testing per ASTM F382) | Results indicate substantial equivalence to legally marketed devices. |
Biocompatibility (Galvanic Corrosion engineering evaluation) | Found to meet the acceptance criteria. |
Substantial Equivalence (Overall Safety & Effectiveness) | The Ulna Plating System has shown to be substantially equivalent to the predicate devices. No new issues of safety and effectiveness have been raised. |
2. Sample Size Used for the Test Set and Data Provenance
The document explicitly states: "No clinical tests are provided for basis of substantial equivalence." This means there was no test set in the context of clinical data. The performance was assessed through non-clinical (mechanical and engineering) tests.
- Test Set Sample Size: Not applicable for clinical data. For non-clinical tests, specific sample sizes (e.g., number of plates, screws, test specimens) are not detailed in this summary.
- Data Provenance: Not applicable for clinical data. For non-clinical testing, the data would have originated from laboratory testing conducted by the manufacturer or a contracted lab. The document does not specify the country of origin for this testing.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of those Experts
Not applicable. As no clinical tests were performed, there was no clinical "ground truth" to be established by experts.
4. Adjudication Method for the Test Set
Not applicable. No clinical test set.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. This device is a bone fixation system, not an AI-powered diagnostic tool. Therefore, an MRMC study related to readers and AI assistance would not be relevant.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was done
Not applicable. This device is a physical implant, not an algorithm or AI.
7. The Type of Ground Truth Used (expert consensus, pathology, outcomes data, etc.)
For the non-clinical performance data, the "ground truth" was established by engineering standards and specifications (e.g., ASTM F382 for mechanical properties, and internal criteria for galvanic corrosion). The comparison was primarily against the performance of legally marketed predicate devices.
8. The Sample Size for the Training Set
Not applicable. There is no mention of a "training set" as this is not an AI/ML device requiring such. The design of the device would have been informed by engineering principles, predicate device designs, and potentially cadaver studies or biomechanical modeling, but not a "training set" in the context of AI.
9. How the Ground Truth for the Training Set Was Established
Not applicable. No training set in the context of AI/ML.
Summary of the Study that Proves the Device Meets Acceptance Criteria:
The study proving the device meets acceptance criteria was a non-clinical performance evaluation. This included:
- Construct testing per ASTM F382: This standard specifies requirements for metallic bone plates and tests their mechanical integrity. The results demonstrated substantial equivalence to predicate devices.
- 4-point bend testing per ASTM F382: This is another mechanical test under the ASTM F382 standard, specifically assessing the bending strength and stiffness of the plates. Results also indicated substantial equivalence to predicate devices.
- Galvanic Corrosion engineering evaluation: This evaluated the potential for corrosion when different metals are in contact, a crucial safety aspect for implants. The evaluation found that the device met acceptance criteria.
The conclusion drawn from these non-clinical tests was that the Ulna Plating System is substantially equivalent to legally marketed predicate devices (specifically K083843 - Locking Anatomic and Composite Plate System, and K112345 - Distal Volar Radius Plating System) in terms of its intended use, indications for use, materials, design features, and sterilization method. No clinical tests were performed, nor were they deemed necessary by the FDA for this 510(k) submission based on the non-clinical data and comparison to predicates.
Ask a specific question about this device
(112 days)
The CLAW® II Polyaxial Compression Plating System is intended to be used for fixation such as:
- · Midfoot and hindfoot arthrodeses or osteotomies
- · Tarsometatarsal arthrodeses (metatarsocuneiform, metatarsocubid, Lapidus)
- · Intercuneiform arthrodeses
- · Naviculocuneiform arthrodeses
- · Talonavicular arthrodeses
- · Calcaneocuboid arthrodeses
- · Lisfranc arthrodeses
- · Mono- or bi-cortical osteotomies in the forefoot, midfoot and hindfoot
- · Fixation of osteotomies for hallux valgus treatment (Scarf and Chevron)
- · Akin osteotomies
- · First metatarsophalangeal arthrodeses
The CLAW® II Polyaxial Compression Plating System consists of plates and screws of various anatomic configurations and lengths. All plates and screws are manufactured from implant grade stainless steel. The plates accept 2.7mm and 3.5mm ORTHOLOCTM 3DSi locking screws.
The ORTHOLOC™ 3DSi Locking Screws are made from implant grade stainless steel and are available with cortical and cancellous thread forms in multiple length and diameters.
The provided text describes a 510(k) premarket notification for the CLAW® II Polyaxial Compression Plating System, demonstrating substantial equivalence to predicate devices rather than a study proving the device meets specific acceptance criteria with performance metrics. Therefore, many of the requested categories related to clinical study design and performance metrics cannot be directly extracted or are not applicable.
Here's an analysis based on the provided text:
1. Table of Acceptance Criteria and Reported Device Performance
This information is not explicitly provided in the document in the format of specific, measurable acceptance criteria and corresponding performance data. The device demonstrates "substantial equivalence" to predicate devices through non-clinical testing.
Acceptance Criteria (Not Explicitly Stated) | Reported Device Performance (Based on Substantial Equivalence) |
---|---|
Mechanical strength/durability comparable to predicates | "The results of the test show that the subject CLAW® II Polyaxial Compression Plating System and ORTHOLOC™ 3DSi Locking Screws can be expected to perform at least as well as the legally marketed predicate identified in this 510(k) submission." |
Polyaxial performance comparable to predicates | Demonstrated through "polyaxial performance testing." |
Design features comparable to predicates | "The design features... are substantially equivalent to the design features of the predicate devices." |
Safety and effectiveness comparable to predicates | "The safety and effectiveness... are adequately supported by the substantial equivalence information, materials information, and analysis data..." |
2. Sample size used for the test set and the data provenance
- Sample Size: Not specified for any test sets. The document describes "worst-case plate analysis, plate mechanical testing, and polyaxial performance testing," but does not detail the number of samples or specimens used in these tests.
- Data Provenance: The studies are non-clinical, likely conducted in a laboratory setting by the manufacturer, Wright Medical Technology, Inc. There is no information on country of origin of data or whether it's retrospective or prospective, as these terms usually apply to clinical studies.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
Not applicable. This device is cleared based on non-clinical substantial equivalence, not on expert-adjudicated ground truth from a clinical data set. The "ground truth" here is the performance of the predicate devices.
4. Adjudication method for the test set
Not applicable, as no external experts were used to establish a ground truth for a clinical test set. The determination of substantial equivalence was made by the FDA based on the presented non-clinical evidence.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. This is not an AI/software device, but a physical orthopedic plating system. No MRMC studies or AI involvement are mentioned.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
Not applicable, as this is a physical medical device, not an algorithm or AI.
7. The type of ground truth used
The "ground truth" in this context is the established safety and effectiveness of the predicate devices. The subject device's performance (mechanical, polyaxial performance) was assessed to be "at least as well as" the predicate devices. The ground truth for the predicate devices themselves would have been established through their original clearance processes, likely including non-clinical testing and potentially clinical data depending on their classification and introduction date.
8. The sample size for the training set
Not applicable, as this is not a machine learning or AI device that requires a training set.
9. How the ground truth for the training set was established
Not applicable, as this is not a machine learning or AI device that requires a training set with established ground truth.
Ask a specific question about this device
Page 1 of 1